ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026
Symptom severity assessment in patients with atrial fibrillation after catheter ablation using a smartphone application.
Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
19 authors.
Emma SandgrenDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0001-7410-3246
Konstanze BetzDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0002-3943-3896
Monika GawalkoDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0003-4619-9062
Astrid HermansDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0002-9034-1479
Zarina HabibiDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0002-0369-7670
Dominique VerhaertDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0003-3477-2589
Suzanne PhilippensDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.
Bianca VorstermansDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0009-0001-0982-2858
Mandy KesselsDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.
David BovenkerkDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0002-2355-8539
Ben J M HermansDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0001-7780-4427
Jeroen M HendriksDepartment of Nursing, Maastricht University Medical Centre, Maastricht, The Netherlands.ORCID 0000-0003-4326-9256
Dennis den UijlDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0002-4158-0545
Sevasti-Maria ChaldoupiDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0003-3938-6193
Justin LuermansDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0001-9598-2286
Theo LankveldDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.
Ulrich SchottenDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Netherlands.ORCID 0000-0003-1532-3315
Kevin VernooyDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0002-8818-5964
Dominik LinzDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, P.Debyelaan 25, Maastricht 6229 HX, the Netherlands.ORCID 0000-0003-4893-0824
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
aimsSymptom severity in atrial fibrillation (AF) influences healthcare use, but conventional assessments lack temporal precision. We evaluated the feasibility of smartphone-based symptom severity assessment after AF catheter ablation and explored predictors and variability of symptom severity. METHODS AND
resultsIn this analysis of the ISOLATION study, 140 patients used a photoplethysmography-supported smartphone application to record heart rhythm, symptoms, and symptom severity three times daily and when symptomatic for 7 days at 3, 6, and 12 months after ablation. Symptom severity was classified using the modified European Heart Rhythm Association scale. A total of 8575 recordings were analysed, of which 11% showed AF. Median adherence was 67%. Symptom severity was higher during AF, in women, and with higher heart rate. Nearly half of AF recordings were asymptomatic.
conclusionSmartphone-based symptom severity assessment after AF ablation is feasible and reveals substantial individual variability beyond rhythm status alone.
Indexed as
Atrial FibrillationCatheter AblationMobile ApplicationsPhotoplethysmographySmartphoneSymptom AssessmentAgedFeasibility StudiesFemaleHeart RateHumansMaleMiddle AgedPredictive Value of TestsSeverity of Illness IndexSymptom BurdenAtrial fibrillationCatheter ablationMobile healthPhotoplethysmographySymptomsSymptom severity
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Symptom severity assessment in patients with atrial fibrillation after catheter ablation using a smartphone application. · full record | OpenQuestion